Thomas F. Ryan Jr. - 02 Nov 2021 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role: Director
Signature: /s/ Kimberly Brown (Attorney in Fact)
Issuer symbol: RGEN
Transactions as of: 02 Nov 2021
Net transactions value: +$264,781
Form type: 4
Filing time: 04 Nov 2021, 17:45:58 UTC
Previous filing: 05 Aug 2021
Next filing: 02 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RGEN	Common Stock	Options Exercise	$164,711	+1,285	+9.6%	$128.18	14,622	02 Nov 2021	Direct	F1
transaction	RGEN	Common Stock	Sale	$388,070	+1,285	+11%	$302.00	13,337	02 Nov 2021	Direct	F2
transaction	RGEN	Common Stock	Sale	$288,000	-1,000	-7.5%	$288.00	12,337	04 Nov 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RGEN	Stock Option (Right to Buy)	Options Exercise	$0	+1,285		$0.000000^*	0	02 Nov 2021	Common Stock	1,285	$128.18	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes three stock option exercises totaling 12,366 shares which were not previously included in the holder's beneficial ownership totals.
F2	$302.00 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $301.85 to $302.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3	This option is currently exercisable